Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2021 | Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis

Divyanshu Dubey • 15 Feb 2021
ACTRIMS 2021
General

Autoimmune encephalitis is a complex condition, with many aspects of causality and treatment incompletely understood. Divyanshu Dubey, MBBS, Mayo Clinic, Rochester, MN, discusses the main challenges currently faced in the field. These include improving diagnosis, as a lack of diagnostic biomarkers means a large percentage of patients are diagnosed based only on clinical judgement. Additionally, treating autoimmune encephalitis successfully with minimal side effects remains a challenge. This interview took place during the ACTRIMS Forum 2021.

Disclosures

Dr. Dubey has consulted for UCB, Immunovant and Astellas Pharma. All compensation for consulting activities is paid to Mayo Clinic. He has a patent pending for KLHL 11-IgG and LUZP4-IgG as markers of neurological autoimmunity and germ cell tumors.

More from Divyanshu Dubey

Updates on peripheral autoimmune neurological conditions
2:44
Updates on peripheral autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Diagnostic work up of autoimmune neurological conditions
3:13
Diagnostic work up of autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Mechanisms and triggers of autoimmune neurological conditions
3:35
Mechanisms and triggers of autoimmune neurological conditions
Divyanshu Dubey • 12 Apr 2022
Immunotherapy strategies for autoimmune disorders of the nervous system
1:43
Immunotherapy strategies for autoimmune disorders of the nervous system
Divyanshu Dubey • 12 Apr 2022

Related Videos

A discussion at EAN 2026 on the impact of climate change on neurological diseases
13:26
A discussion at EAN 2026 on the impact of climate change on neurological diseases
Amalia Ghergu et al. • 28 Jun 2026
Medically assisted dying and palliative care in neurological disorders
1:39
Medically assisted dying and palliative care in neurological disorders
Katarina Rukavina • 20 Apr 2026
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
2:42
Skin biopsy in long COVID: LCCS study findings on neuropathy and persistent anosmia
Christopher Gibbons • 21 Apr 2026
Using VJNeurology to stay updated with research advances
0:38
Using VJNeurology to stay updated with research advances
Ana Catarina Fonseca • 5 Feb 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals